The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action

Trends Endocrinol Metab. 2006 Aug;17(6):236-42. doi: 10.1016/j.tem.2006.06.007. Epub 2006 Jul 11.

Abstract

The insulin-like growth factor-I receptor (IGF-IR) mediates the biological actions of both IGF-I and IGF-II. The IGF-IR is expressed in most transformed cells, where it displays potent antiapoptotic and cell-survival activities. IGF-IR levels are tightly regulated by the concerted action of secreted (e.g. peptide and steroid hormones, growth factors and cytokines) and cellular (e.g. transcription factors, oncogenes and tumor suppressors) factors. The mode of action of many tumor suppressors involves transcriptional suppression of the IGF-IR gene, with a subsequent reduction in cell-surface IGF-IR concentrations and IGF-I action. Loss-of-function mutation of tumor suppressors, a common theme in human cancer, can lead to aberrant regulation of IGF-IR gene expression.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Biomarkers, Tumor / metabolism
  • Breast Neoplasms / metabolism
  • Cell Transformation, Neoplastic / metabolism
  • Gene Expression Regulation
  • Humans
  • Insulin-Like Growth Factor I / physiology
  • Mutant Proteins / metabolism
  • Oncogenes / physiology*
  • Promoter Regions, Genetic
  • Receptor, IGF Type 1 / genetics*
  • Receptor, IGF Type 1 / metabolism*
  • Receptor, IGF Type 1 / physiology
  • Transcription Factors / metabolism
  • Tumor Suppressor Protein p53 / physiology
  • Tumor Suppressor Proteins / metabolism*

Substances

  • Biomarkers, Tumor
  • Mutant Proteins
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • Insulin-Like Growth Factor I
  • Receptor, IGF Type 1